Nicardipine

MedicalFeed Health News Feed

Nicardipine Offers Fast Track to Target Blood Pressure During Neurologic Emergencies - QualityPoint Technologies

qualitypointtech.net — “Nicardipine gets to target blood pressure rapidly during neurologic emergencies, but is associated with a risk for hypotension when combined with other medications. Medscape Medical News” View full resource at qualitypointtech.net

View Related
Share

Most Recently Shared on October 2, 2010 at 5:12 am By:

Nicardipine Offers Fast Track to Target Blood Pressure During Neurologic Emergencies: Nicardipine gets to target b... http://bit.ly/cTFHXQ

Prophylactic Intragraft Injection of Nicardipine Prior to Saphenous Vein Graft Percutaneous Intervention for the Prevention of No-reflow: A Review and Comparison to Protection Devices | Journal of Invasive Cardiology

invasivecardiology.com — “Prophylactic Intragraft Injection of Nicardipine Prior to Saphenous Vein Graft Percutaneous Intervention for the Prevention of No-reflow: A Review and Comparison to Protection Devices | Journal of Invasive Cardiology” View full resource at invasivecardiology.com

View Related
Share

Most Recently Shared on May 12, 2011 at 4:28 pm By:

Invasive Cardiology Medical Journal and Cardiology

Review: Effects of prophylactic intragraft nicardipine injection to prevent no-reflow during SVG intervention. http://tinyurl.com/3mp5eu3

1 year ago...

Emergency Med Medical News about Blood Pressure

mdlinx.com — “Nicardipine Infusion for Blood Pressure Control in Patients with Subarachnoid Hemorrhage” View full resource at mdlinx.com

View Related
Share

Most Recently Shared on June 14, 2010 at 12:28 pm By:

Sandeep Pulim MD Doctor, Health Communicator, and Physician

Nicardipine Infusion for Blood Pressure Control in Patients with Subarachnoid Hemorrhage: Neurocritical... http://bit.ly/cZ4MNQ #ER #mdlinx

Drugs and Devices OW OW Health

New Study Demonstrates Ready-to Use Cardene I.V. More Effective than Labetalol for Immediate Control of Blood Pressure in Emergency Room Patients - Drugs.com MedNews

drugs.com — “CLUE Data Presented During the 2010 American College of Sep 28, 2010 - Results from the CLUE study, a head-to-head comparison between Ready-to-Use Cardene I.V.” View full resource at drugs.com

View Related
Share

Most Recently Shared on September 29, 2010 at 5:14 pm By:

New Study Demonstrates Ready-to Use Cardene I.V. More Effective than Labetalol for Immediate Control of Blood... http://bit.ly/asAM57 #drug

Endocrinology Article | acute hypertension

mdlinx.com — “A randomized Comparative effectiveness trial of IV nicardipine versus Labetalol Use in the Emergency department” View full resource at mdlinx.com

View Related
Share

Most Recently Shared on June 29, 2011 at 2:43 am By:

Sandeep Pulim MD Doctor, Health Communicator, and Physician

A randomized Comparative effectiveness trial of IV nicardipine versus Labetalol Use in the Emergency depar... http://bit.ly/jd1FaL #endo

11 months ago...

News-Medical.Net Health News

Cardene I.V. more effective than intravenous labetalol for BP management in acute stroke patients

news-medical.net — “EKR Therapeutics, Inc., a specialty pharmaceutical company commercializing acute-care hospital products, today said that interim study data1 demonstrate that Cardene® I.V. (nicardipine hydrochloride) is significantly more effective than intravenous labetalol for the management of blood pressure (BP) in stroke patients.” View full resource at news-medical.net

View Related
Share

Most Recently Shared on January 12, 2010 at 8:55 am By:

Cardene I.V. more effective than intravenous labetalol for BP management in acute stroke patients: EKR Therapeutic... http://bit.ly/91grUv

News-Medical.Net Health News

USPTO issues two new patents for EKR Therapeutics' RTU Cardene I.V. Premixed Injection

news-medical.net — “EKR Therapeutics, Inc., a specialty pharmaceutical company focused on commercializing acute-care hospital products, today announced that the US Patent and Trademark Office has issued two new patents covering methods of treatment and methods of preparation for the Company's Ready-to-Use (RTU) Cardene® I.V. (nicardipine hydrochloride) Premixed Injection.” View full resource at news-medical.net

View Related
Share

Most Recently Shared on February 17, 2010 at 7:55 am By:

USPTO issues two new patents for EKR Therapeutics' RTU Cardene I.V. Premixed Injection: EKR Therapeutics, Inc., a ... http://bit.ly/dl5tJr

News-Medical.Net Health News

Ready-to-Use Cardene I.V. lowers acutely elevated blood pressure: CLUE study

news-medical.net — “Results from the CLUE study, a head-to-head comparison between Ready-to-Use Cardene I.V. (nicardipine) and labetalol in the emergency room, showed that Ready-to-Use Cardene I.V. lowers acutely elevated blood pressure more effectively than labetalol. These data were presented today at the annual meeting of the American College of Emergency Physicians (ACEP) in Las Vegas, Nevada.” View full resource at news-medical.net

View Related
Share

Most Recently Shared on September 29, 2010 at 1:18 pm By:

Stroke News: Ready-to-Use Cardene I.V. lowers acutely elevated blood pressure: CLUE study: Results from the CLUE... http://twurl.nl/rdas0m

medical_tweets Health News

Interim Study Data Indicate Improved Blood Pressure Management With Cardene(R) I.V. Compared To Labetalol In Patients With Acute Stroke

medicalnewstoday.com — “EKR Therapeutics, Inc., a specialty pharmaceutical company commercializing acute-care hospital products, today said that interim study data1 demonstrate that Cardene® I.V. (nicardip” View full resource at medicalnewstoday.com

View Related
Share

Most Recently Shared on January 13, 2010 at 5:37 am By:

Interim Study Data Indicate Improved Blood Pressure Management With Cardene(R) I.V. Compared To Labetalol In Patients.. http://bit.ly/5t1fvN